Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chaoju Eye Care Holdings's ROE % for the quarter that ended in Dec. 2025 was 5.90%. Chaoju Eye Care Holdings's PB Ratio for the quarter that ended in Dec. 2025 was 0.72.
Chaoju Eye Care Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 8.19%.
Chaoju Eye Care Holdings ROE % Adjusted to Book Value Related Terms
Chaoju Eye Care Holdings ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Chaoju Eye Care Holdings's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chaoju Eye Care Holdings ROE % Adjusted to Book Value Chart
HKSE:02219 vs HCA, THC, EHC: ROE % Adjusted to Book Value Comparison
For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chaoju Eye Care Holdings ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Chaoju Eye Care Holdings's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 8.19% mean?
Chaoju Eye Care Holdings (HKSE:02219) has a ROE % Adjusted to Book Value of 8.19% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Chaoju Eye Care Holdings and its competitors.
Is Chaoju Eye Care Holdings' ROE % Adjusted to Book Value too high?
Chaoju Eye Care Holdings' current ROE % Adjusted to Book Value is 8.19%. Overall, Chaoju Eye Care Holdings has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chaoju Eye Care Holdings' ROE % Adjusted to Book Value compare to HCA and THC?
Chaoju Eye Care Holdings' ROE % Adjusted to Book Value of 8.19% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Chaoju Eye Care Holdings and its competitors. Chaoju Eye Care Holdings's current ROE % Adjusted to Book Value is 8.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chaoju Eye Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings (HKSE:02219) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.47, compared to a current price of HK$2.47 — trading 28.8% below its estimated fair value. The current ROE % Adjusted to Book Value is 8.19%. Chaoju Eye Care Holdings' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Chaoju Eye Care Holdings (HKSE:02219), the current ROE % Adjusted to Book Value is 8.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chaoju Eye Care Holdings (HKSE:02219) Overvalued in 2026?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings stock appears to be undervalued.
The current stock price of HK$2.47 is trading 28.8% below its estimated GF Value™ of HK$3.47.
GuruFocus considers Chaoju Eye Care Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02219:
ROE % Adjusted to Book Value: 8.19%
GF Value™: HK$3.47 vs. price of HK$2.47 (28.8% below fair value)
No single metric tells the full story. See the HKSE:02219 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chaoju Eye Care Holdings Ltd is an ophthalmic medical service group in North China engaged in the provision of in-patient services, out-patient services, and sales of optical products. The company generates revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control, and the provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
93GF Score
Get the complete analysis for HKSE:02219
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02219 has been successfully added to your 
